# 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates

> **NCT00886457** · PHASE1 · TERMINATED · sponsor: **Nevada Cancer Institute** · enrollment: 3 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Decitabine and Pegylated Interferon-Alfa 2B

## Key facts

- **NCT ID:** NCT00886457
- **Lead sponsor:** Nevada Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2010-08
- **Final completion:** 2010-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2011-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00886457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00886457, "5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00886457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*